Imperial Biotech Private Limited, a active private limited company, was established on 29 June 2020 in New Delhi, Delhi, India. Engaging in diagnostic centers & pathology labs within the manufacturing sector, it holds CIN: U51397DL2020PTC365353. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.27 M.
It upholds a compliant status. Its leadership includes Darshitam Goyal (Director), Swati Goyal (Additional Director). Past directors included Sumit Vij. It holds ₹6.86 Cr open charges and ₹4.60 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 32-A, First Floor Patparganj Village Mayur Vihar Phase-I, New Delhi, Delhi, 110091.
U51397DL2020PTC365353
365353
29 June 2020
₹5.00 M
₹0.27 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Imperial Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Darshitam Goyal | Director | 29 Jun 2020 | Current |
| Swati Goyal | Additional Director | 29 Aug 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Imperial Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 41.6% increase. The company also saw a substantial improvement in profitability, with a 71.23% increase in profit. The company's net worth Soared by an impressive increase of 260.25%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Imperial Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹68,600,000.00
₹46,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Sep 2025 | Indian Overseas Bank | ₹4.75 Cr | Open |
| 09 Sep 2022 | Indian Overseas Bank | ₹2.10 M | Open |
| 26 Feb 2021 | Indian Overseas Bank | ₹1.90 Cr | Open |
| 18 Jul 2025 | Others | ₹4.25 Cr | Satisfied |
| 18 Jul 2025 | Others | ₹3.50 M | Satisfied |
Explore comprehensive loan charge details -
Imperial Biotech has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Imperial Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Imperial Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Indian Overseas Bank amounted to Rs. 47.50 M with Charge ID 101175323 was registered on 16 Sep 2025. was documented.
Progress on A charge registered on 18 Jul 2025 via Charge ID 101131105 with Others was fully satisfied on 11 Sep 2025. was documented.
The activity A charge registered on 18 Jul 2025 via Charge ID 101131102 with Others was fully satisfied on 08 Sep 2025. was completed.
A charge with Others of Rs. 3.50 M registered on 18 Jul 2025 with Charge ID 101131102 was modified on 29 Jul 2025. was recorded as a recent event.
A charge with Others of Rs. 42.50 M registered on 18 Jul 2025 with Charge ID 101131105 was modified on 29 Jul 2025. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 3.50 M with Charge ID 101131102 was registered on 18 Jul 2025. was completed.
The CIN of Imperial Biotech Private Limited is U51397DL2020PTC365353.
Imperial Biotech Private Limited is headquartered at 32-A, First Floor Patparganj Village Mayur Vihar Phase-I, New Delhi, Delhi, 110091.
Imperial Biotech Private Limited was incorporated on 29 June 2020.
The current directors of Imperial Biotech Private Limited are
The primary industry of Imperial Biotech Private Limited is Manufacturing.
Imperial Biotech Private Limited is unlisted.
The authorized capital of Imperial Biotech Private Limited is ₹5.00 M, and the paid-up capital is ₹0.27 M.
The compliance status of Imperial Biotech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX